Cardiovascular disease
Conditions
Interventions
Measurement of skeletal muscle mass index (SMI) and muscle mass in the lower limb using bioelectrical impedance analysis (BIA) and evaluation of frailty status using four scales (The Edmonton Frail
Sponsors
Department of Cardiology, Tsuyama Chuo Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients required hospitalization due to cardiovascular disease
Exclusion criteria
Exclusion criteria: 1. Patients with pacemaker, implantable cardioverter defibrillator or cardiac resynchronization therapy devise 2. Inadequate patients by physician's discresion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between skeletal muscle mass index (SMI), muscle mass in the lower limb measured using bioelectrical impedance analysis (BIA) and frailty status | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assessment of cut-off value, sensitivity and specificity of skeletal muscle mass index (SMI) and muscle mass in the lower limb for the diagnosis of frailty status 2. Relationship of frailty status, skeletal muscle mass index (SMI) and muscle mass in the lower limb and in-hospital episode of fall or delirium or later major adverse outcomes (all cause death and heart failure-related admission) | — |
Countries
Japan
Contacts
Public ContactKei Yunoki
Tsuyama Chuo Hospital Department of Cardiology
Outcome results
None listed